Cronos (CRON) Gross Profit Growth (3y) (2021 - 2026)
Cronos (CRON) Gross Profit Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 7.62% |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | 4.71% |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | -7.64% |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | 12.55% |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | -9.13% |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 24.80% |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | 0.95% |
| 10 | Cronos | 1.08 Bn | 261.26 Mn | 19.15 Mn | 87.04% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 87.04% |
| Dec 31, 2025 | 134.22% |
| Sep 30, 2025 | 79.99% |
| Jun 30, 2025 | 49.72% |
| Mar 31, 2025 | 25.63% |
| Dec 31, 2024 | 79.01% |
| Sep 30, 2024 | 90.81% |
| Jun 30, 2024 | 33.87% |
| Mar 31, 2024 | 52.02% |
| Dec 31, 2023 | 28.63% |
| Sep 30, 2023 | 66.10% |
| Jun 30, 2023 | 45.19% |
| Mar 31, 2023 | 34.85% |
| Dec 31, 2022 | 27.28% |
| Sep 30, 2022 | 44.26% |
| Jun 30, 2022 | 1.83% |
| Mar 31, 2022 | 64.53% |
| Dec 31, 2021 | 0.07% |